Experience

Bach Pharma

• United States
• Biotechnology
• 1 - 100 Employee

• Business Advisor- Collaborations/Partnering

  • Jun 2009 - Mar 2018

  Greater Boston Area ★ Manage penetration and introduction to international partners for this privately held and funded pharmaceutical company. ★ Introduced client leaders to key contacts within the industry ★ Currently in discussions with several major industrial companies. ABOUT BACH PHARMA Bach Pharma, Inc., a privately held pharmaceutical company engaged in the discovery, development and commercialization of a new therapeutic family for the treatment of life threatening oxidative stress… Show more ★ Manage penetration and introduction to international partners for this privately held and funded pharmaceutical company. ★ Introduced client leaders to key contacts within the industry ★ Currently in discussions with several major industrial companies. ABOUT BACH PHARMA Bach Pharma, Inc., a privately held pharmaceutical company engaged in the discovery, development and commercialization of a new therapeutic family for the treatment of life threatening oxidative stress related diseases as well as other serious illnesses. Show less



Akrivis Technologies, LLC

• Chief Financial Officer

  • Sep 2015 - Jan 2018

  4 Technology Way Salem Massachusetts / One Broadway Cambridge Massachusetts Akrivis Technologies, LLC was a privately held biopharmaceutical company committed to the early detection, diagnosis and treatment of serious and life-threatening diseases based on its patented Z-TECT™ technology platform



Seldon Technologies, Inc

• Senior Consultant and Vice President of Finance

  • Dec 2012 - Mar 2016

  Windsor, Vermont ★ Lead all matters of corporate finance; have addressed accounting, filing, and financial statement issues while creating financial forecasts for the benefit of investors. ★ Further secured patent protection for seven product designs through the retention of an intellectual property law firm. ★ Manages relationships with 10 foreign limited partners to accelerate growth in the company's product portfolio; provides guidance on EB5 documentation requirements and green card… Show more ★ Lead all matters of corporate finance; have addressed accounting, filing, and financial statement issues while creating financial forecasts for the benefit of investors. ★ Further secured patent protection for seven product designs through the retention of an intellectual property law firm. ★ Manages relationships with 10 foreign limited partners to accelerate growth in the company's product portfolio; provides guidance on EB5 documentation requirements and green card applications.(Seldon Clean Water Limited Partnership) ABOUT SELDON TECHNOLOGIES Seldon Technologies had offered safe, reliable water purification products that exceed US EPA Drinking Water Standards without chemicals, heat, waiting time or the need for power. The patented Nanomesh™ technologies offered a fundamental advancement in water filtration and ensures the quality water at the final point-of-use. Company is no longer in existence.

• Finance

  • 2012 - 2016



HydroCision Inc.

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Senior Financial Advisor

  • 2006 - Jul 2010

  ★ Maintained the continuity of operations by closing $20MM in funding from a combination of initial introduction to debt and equity financing partners. ★ Prepared and reviewed financial information and participated in negotiation of term sheets. ABOUT HYDROCISION INC. HydroCision is the leading developer, manufacturer, and marketer of fluidjet based surgical tools for the spine market. Incorporated in 1994, HydroCision's proprietary fluidjet technology is the basis of a new… Show more ★ Maintained the continuity of operations by closing $20MM in funding from a combination of initial introduction to debt and equity financing partners. ★ Prepared and reviewed financial information and participated in negotiation of term sheets. ABOUT HYDROCISION INC. HydroCision is the leading developer, manufacturer, and marketer of fluidjet based surgical tools for the spine market. Incorporated in 1994, HydroCision's proprietary fluidjet technology is the basis of a new surgical modality leveraging compelling features and offering application versatility. The company is currently developing a broad range of fluidjet-based products to meet the needs of spine specialists. Show less



HemaQuest Pharmaceuticals

• COO/ VP / Co-Founder

  • 2007 - 2009

  Greater Boston Area ★ Assumed a lead role in the negotiation of corporate licenses and office leases, and the capture of $20MM in funding over two rounds. ★ Effectively managed operations, finance, intellectual property, tax filings, and human resources. ★ Negotiated partnerships with four universities to launch sponsored research programs. ABOUT HEMAQUEST PHARMACEUTICALS HemaQuest Pharmaceuticals, Inc., a pharmaceutical company, develops small molecule therapeutics based on its short… Show more ★ Assumed a lead role in the negotiation of corporate licenses and office leases, and the capture of $20MM in funding over two rounds. ★ Effectively managed operations, finance, intellectual property, tax filings, and human resources. ★ Negotiated partnerships with four universities to launch sponsored research programs. ABOUT HEMAQUEST PHARMACEUTICALS HemaQuest Pharmaceuticals, Inc., a pharmaceutical company, develops small molecule therapeutics based on its short chain fatty acid derivative (SCFAD) technologies to treat anemia and other blood disorders. Show less



Pintex Pharmaceuticals Inc

• United States
• Biotechnology Research

• CEO/ Treasurer/ Director

  • 2003 - 2006

  Greater Boston Area ★ Supervised all operations, finance, corporate development, legal, and human resources functions. ★ Developed an effective business model designed to drive business growth. ★ Coordinated all facets of the corporate sale process, working with investment bankers. ★ Led critical initial and follow on discussions and identified potential acquiring companies; conducted due diligence and hosted negotiations. ★ Successfully sold the company to Vernalis, a leading… Show more ★ Supervised all operations, finance, corporate development, legal, and human resources functions. ★ Developed an effective business model designed to drive business growth. ★ Coordinated all facets of the corporate sale process, working with investment bankers. ★ Led critical initial and follow on discussions and identified potential acquiring companies; conducted due diligence and hosted negotiations. ★ Successfully sold the company to Vernalis, a leading development stage pharmaceutical company. Show less



Paratek Pharmaceuticals

• United States
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• COO, Executive VP/ Initial Corporate Employee

  • 1997 - 2003

  Greater Boston Area As initial employee succeeded in launching start-up Paratek Pharmaceuticals, now publically traded as PRTK. Sourced through Board member's prior contacts, negotiated and completed a critical strategic collaboration with a major pharmaceutical partner. Partner agreed to make pre-commercial milestone payments of as much as $95 million plus product royalties and equity investment in a collaboration to develop antibiotics targeting bacteria resistant to current drugs on market. Completed… Show more As initial employee succeeded in launching start-up Paratek Pharmaceuticals, now publically traded as PRTK. Sourced through Board member's prior contacts, negotiated and completed a critical strategic collaboration with a major pharmaceutical partner. Partner agreed to make pre-commercial milestone payments of as much as $95 million plus product royalties and equity investment in a collaboration to develop antibiotics targeting bacteria resistant to current drugs on market. Completed Series A funding approximately 11 months prior to close of partnership deal. Completed due diligence, negotiations and financials to support the agreed pre-money valuation between the partners and closed the deal at a multiple increase in the Company's valuation. Subsequently built organization and teams with additional closing of $40+ million of investor funding as COO. Company currently in Phase III clinical trials with new broad spectrum oral and I.V. antibiotic with other potential candidates for significant disease areas. Simultaneously sourced 30,000 square feet adjacent to the founder’s labs and managed build out of corporate labs and company headquarters. Show less



Cohesive Technologies

• COO/ Treasurer/ Co-Founder

  • 1991 - 1997

  Greater Boston Area Bio-separations Company acquired by Thermo Fisher Scientific in 2006. Secured and closed $10 million of venture capital and angel funding during tenure as well as product endorsements from large industry customers. Responsiblities included establishment of and management of company operations, initial and follow on financings, related tax filings, patent administration and new filings, human resources, corporate development and legal affairs of company.



Boston Bay Capital Inc

• COO/VP

  • 1982 - 1989

  Greater Boston Area A boutique financial services brokerage firm with a small investment banking team that secured in excess of $150 million over a five-year time frame in private placements for various investment opportunities especially historic property rehabs. Subsequently successfully marketed the concept of leveraging low-income housing tax credit partnerships, traditionally reserved for individuals at $5k per investment, to the corporate company world at $5-10M per investment or more, in order for the… Show more A boutique financial services brokerage firm with a small investment banking team that secured in excess of $150 million over a five-year time frame in private placements for various investment opportunities especially historic property rehabs. Subsequently successfully marketed the concept of leveraging low-income housing tax credit partnerships, traditionally reserved for individuals at $5k per investment, to the corporate company world at $5-10M per investment or more, in order for the investor to substantially reduce its effective corporate tax rate and increase its related earnings per share. Closed the initial offering with a major participating corporation, whose investment of $2 million subsequently rose to 39% of total future offerings.This company among others as well invested over $250 million over an extended time period post this closing. Market ultimately expanded enough to help fund the affordable housing market expansion lasting for over 10 years and continuing. Show less



PwC

• Professional Services
• 700 & Above Employee

• Senior Tax Staff

  • Jan 1977 - Dec 1981

  Paris France; Boston, Massachusetts Senior Accountant at Price Waterhouse. Responsible for a variety of federal, state and international tax matters for clients across all industries, initially based in Paris, France covering clients in southern Europe (Spain, Portugal, Italy, Greece, Yugoslavia, Switzerland, etc.), Northern Africa (Libya), and Asia (Japan and Saudi Arabia). Relocated to Boston office in late 1979.